DV
Dividend Vision

LGND — Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated (LGND)

Its deepest 1-year drawdown was 14.1%.

LGND is a single-stock equity holding in Ligand Pharmaceuticals, a healthcare company. As an individual stock rather than a diversified fund, it does not have a stated dividend distribution rate, expense ratio, or fund objective. This holding appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing a dividend income strategy.

LGND key facts

Asset type
Stock
Asset class
Equity
Inception date
11/18/1992
Last close
$294.60
Market cap
$5,872,930,304
Average volume
197200.0
Ex-dividend date
07/02/2010
Beta
0.983
Payout ratio
0.0
P/E ratio
29.7571
Forward P/E
32.8947
EPS
$9.90